声明:因水平有限,错误不可避免,或有些信息非最及时,欢迎留言指出。本文仅作医疗健康相关药物介绍,非治疗方案推荐(若涉及);本文不构成任何投资建议。2月11日,吉利德发布2024年财报,全年营收287.54亿美元,同比增长6%。其中产品收入286.10亿美元,同比增长6%。这主要是由于HIV、肿瘤和肝病药物的销售额增长。而艾滋病(HIV)业务营收196.12亿美元(+8%),占总营收的68.2%;...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.